Bpc-157 tell me for it

BPC-157 is an experimental peptide that may support tissue repair, but the evidence in people is very limited and potential tumor-related risks deserve caution.

• Tissue repair: Animal studies suggest it can promote new blood-vessel growth and cell migration at injured sites, with reported effects involving tendons, ligaments, and nerves. 1 2
• VEGF and tumor concerns: BPC-157 may increase VEGF and growth-hormone receptors, pathways that could theoretically support tumor growth. The transcripts describe this as a potential concern, not a demonstrated human outcome. 3
• Reported regimen—not established guidance: One episode describes a commonly reported regimen of 300–500 micrograms injected subcutaneously two or three times weekly for about eight weeks, followed by an 8–10-week break. It also cautions against interpreting this as a recommendation; safety and effectiveness are not established. 4
• Evidence limits: Most evidence comes from animal research; human clinical evidence is scarce, and many claims come from anecdotes rather than rigorous trials. 5 6